Vident Investment Advisory’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,292
Closed -$426K 714
2019
Q3
$426K Buy
4,292
+481
+13% +$45.7K 0.04% 381
2019
Q2
$352K Sell
3,811
-1,618
-30% -$154K 0.03% 412
2019
Q1
$512K Buy
5,429
+719
+15% +$62.9K 0.03% 566
2018
Q4
$301K Sell
4,710
-3,863
-45% -$285K 0.02% 710
2018
Q3
$767K Sell
8,573
-731
-8% -$64.6K 0.03% 550
2018
Q2
$739K Buy
9,304
+1,677
+22% +$139K 0.03% 513
2018
Q1
$693K Sell
7,627
-376
-5% -$36.1K 0.03% 486
2017
Q4
$835K Buy
8,003
+5,112
+177% +$577K 0.04% 406
2017
Q3
$421K Buy
+2,891
New +$394K 0.02% 551
2016
Q4
Sell
-6,193
Closed -$796K 411
2016
Q3
$796K Sell
6,193
-6,114
-50% -$662K 0.11% 308
2016
Q2
$1.35M Buy
12,307
+577
+5% +$59.7K 0.19% 250
2016
Q1
$1.17K Buy
11,730
+5,435
+86% +$560K 0.07% 346
2015
Q4
$754K Sell
6,295
-10,608
-63% -$1.23M 0.1% 342
2015
Q3
$1.83M Sell
16,903
-16,070
-49% -$1.99M 0.25% 107
2015
Q2
$3.82M Buy
32,973
+10,404
+46% +$1.19M 0.51% 26
2015
Q1
$2.6M Buy
+22,569
New +$2.7M 0.52% 15

Other funds holding CELG

Vident Investment Advisory's CELG Position: Q4 2019 in Review

Vident Investment Advisory sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,292 shares — an estimated $426K sold.

Vident Investment Advisory first reported a position in CELG in Q1 2015 and held it in 16 quarters. The position peaked at $3.82M in Q2 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Vident Investment Advisory reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Vident Investment Advisory sold 4,292 Celgene Corp shares in Q4 2019, an estimated $426K.
  • Vident Investment Advisory first reported a position in Celgene Corp in Q1 2015 and held it in 16 quarters.
  • Vident Investment Advisory's Celgene Corp position peaked at $3.82M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Vident Investment Advisory's 13F filing for Q4 2019, filed 11 Feb 2020.